SecBot SecBot
8-K ·Filed Jun 23, 2026

ALTO

Alto Ingredients, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed4mo ago SEC0001213900-26-071111
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor future 8-K filings for specific grant amounts and exercise prices under the new plan, which could signal management's incentive focus. No price-moving catalyst from this routine governance update.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
ALTO ▼ -20.40% at T+60d
NEUTRAL call -20.40% · α vs SPY -23.23% · entry $5.05 → $4.02
Entry = T+0 close
Jun 23, 2026
via day close
T+1d
-1.39%
call -1.39% · α -1.53%
$4.98
settled 4mo ago
T+5d
+18.42%
call +18.42% · α +16.71%
$5.98
settled 4mo ago
T+20d
+0.49%
call +0.49% · α -1.44%
$5.08
settled 3mo ago
T+60d
-20.40%
call -20.40% · α -23.23%
$4.02
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Alto Ingredients filed an 8-K confirming stockholder approval of the 2026 Omnibus Incentive Plan and the election of five directors at the 2026 annual meeting. The plan replaces the 2016 predecessor plan and authorizes 7,000,000 new shares for equity incentives, a routine compensatory change that does not alter near-term financials or operations.

Key Facts

  • Stockholders approved the 2026 Omnibus Incentive Plan on June 23, 2026, authorizing up to 7,000,000 shares of common stock.
  • The plan replaces the Predecessor Plan (2016 Stock Incentive Plan) and will remain effective until June 23, 2036.
  • Five director nominees were elected with over 94% of votes cast in favor; say-on-pay passed with 93.4% support.
  • RSM US LLP was ratified as independent auditor for FY 2026 with 97.6% of votes cast in favor.
  • No officer departures, material financial data, or guidance were disclosed in this filing.

Financial Impact

No immediate financial impact; the 7,000,000-share authorization represents approximately 17% of diluted shares outstanding, but no grants have been made.

dilution

Risk Factors

  • Potential future dilution if large equity grants are made under the 2026 Plan
  • Say-on-pay support (93.4%) is strong but below prior-year levels, suggesting minor shareholder concerns

Market Snapshot

Exchange
Nasdaq
Sector
Industrial Organic Chemicals
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-071111
Document: ea0295688-8k_alto.htm0001213900-26-071111
Document: 0001213900-26-071111-index-headers.html0001213900-26-071111
Document: 0001213900-26-071111-index.html0001213900-26-071111
Document: 0001213900-26-071111.txt0001213900-26-071111
8 reports for ALTO
Performance horizon
100% Hit rate @ T+20 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +42.04%Mar 4, 2026
Filters
Rows
Reports for ALTO — sortable, filterable
TypeNow
Sep 22, 2026
5w ago
Institutional Cluster
BEARISH ★ 4/10
$3.82 $3.56▲ +6.81%▲ +6.25%$3.72 (+2.62%)
Jun 23, 2026
18w ago
8-K
NEUTRAL ★ 3/10
$5.05 $5.08▲ +0.49%▼ −1.44%$3.72 (−26.34%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$5.65 $5.67▲ +0.35%▼ −1.54%$3.72 (−34.16%)
May 26, 2026
22w ago
EFFECT
NEUTRAL ★ 4/10
$5.22 $4.98▼ −4.60%▼ −2.65%$3.72 (−28.74%)
May 6, 2026
24w ago
8-K
MIXED ★ 6/10
$4.54 $5.53▲ +21.81%▲ +18.67%$3.72 (−18.06%)
Apr 30, 2026
25w ago
DEFA14A
NEUTRAL ★ 2/10
$5.43 $5.71▲ +5.16%▼ −0.11%$3.72 (−31.49%)
Mar 4, 2026
33w ago
8-K
BULLISH ★ 7/10
$4.02 $4.67▲ +16.17%▲ +19.96%$3.72 (−7.46%)
Mar 4, 2026
33w ago
Press Release
BULLISH ★ 8/10
$4.02 $4.67▲ +16.17%▲ +19.96%$3.72 (−7.46%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 23, 2026